Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5299

7 FDA label images from Nucare Pharmaceutials, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68071-5299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceutials, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of rosuvastatin calcium, showing the molecular arrangement including fluorophenyl, methyl, hydroxyl groups, a calcium ion (Ca2+), and other characteristic chemical bonds.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line chart showing cumulative incidence (%) over years comparing Rosuvastatin calcium (labeled as Rosuva) to Placebo. The graph includes a hazard ratio (HR) of 0.56 with 95% confidence interval (0.46-0.69) and a p-value less than 0.001. The chart shows Rosuvastatin having a lower incidence rate than Placebo. Below the graph is a table indicating the number of subjects at risk at different time points for both RSV and Placebo groups.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A data table presenting the number of events comparing Rosuvastatin 20 mg to placebo 20 mg across various cardiovascular endpoints. It includes event rates per 1000 patient-years, hazard ratios (HR) with 95% confidence intervals (CI), and p-values. A forest plot on the right visually represents hazard ratios for primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
Box plot chart depicting percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, across various doses ranging from 10 mg to 80 mg. The vertical axis shows percent change from 0 to -75, illustrating LDL-C reduction at each dose.*
FDA Label Image
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Pdp (68071 5299 9)

Pdp (68071 5299 9)
Label for Rosuvastatin 5 mg tablets by NuCare Pharmaceuticals, Inc. The label displays the NDC 68071-5299-9 and indicates the product contains 90 film-coated tablets. It states each tablet contains Rosuvastatin Calcium USP equivalent to 5 mg Rosuvastatin. The label includes storage instructions to keep at 68-77°F and warns to keep out of reach of children. Additional lot, serial, expiration, and manufacturer NDC details are printed, along with common regulatory and usage notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.